AseBio and Alira Health Partner to Foster Market Access for Biotech Startups

News
Published on:
September 27, 2022

Alira Health, a global healthcare advisory and technology company, and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.

Together, AseBio and Alira Health will provide a market access mentoring program for AseBio members to promote access to innovation.

Alira Health, a member of AseBio since Spring 2022, will pair its experienced market access consultants with companies to improve their value proposition, navigate the ecosystem, and properly define their market access needs. The program features a 40-hour service package that includes an initial meeting, background analysis, tailored orientation session for market access and pricing, and gap analysis.

It is a pleasure for us as Alira Health to collaborate with AseBio in this mentoring program. We hope that this will allow us to help biotech companies have better access to the market, and in addition, train companies in areas where they need development.”
Chus Castillo Vice President, Market Access, Alira Health (Iberia)

The program will start in November 2023, and application is open to all AseBio SMEs. Three companies will be selected for the inaugural program.

Ion Arocena, General Director at AseBio, and Chus Castillo, Vice President of Market Access at Alira Health (Iberia), attended the signing event.

“It is a pleasure for us as Alira Health to collaborate with AseBio in this mentoring program. We hope that this will allow us to help biotech companies have better access to the market, and in addition, train companies in areas where they need development”, says Chus Castillo, Vice President of Market Access at Alira Health (Iberia).

Would you like to learn more about Alira Health’s partnership with AseBio? Watch this interview with our team.

Related news

Events February 22, 2024
Bio-Europe Spring
Connect with our biotech experts onsite in Barcelona at Bio-Europe Spring. How can we support your development plan and funding path?
Biotech
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
Blog February 14, 2024
Biopharma in 2024: The Industry Outlook
Insights from recent J.P. Morgan Healthcare Conference including what's changed in biopharma since last year and what to expect this year.
Biopharma Biotech
Events February 1, 2024
2023 BioRegion Report Presentation
Biotech Spain
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
News January 18, 2024
Alira Health and Biocat Announce Startup Support Program for 2024
Alira Health and Biocat, a strategic stakeholder building the Catalan life sciences and ecosystem, partnered to foster Market Access for startups.
Market Access Startups
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.